1. Home
  2. SIDU vs PROK Comparison

SIDU vs PROK Comparison

Compare SIDU & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

HOLD

Current Price

$2.13

Market Cap

286.7M

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$2.01

Market Cap

331.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
PROK
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.7M
331.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SIDU
PROK
Price
$2.13
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.40
AVG Volume (30 Days)
17.5M
1.0M
Earning Date
03-30-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,623,538.00
$744,000.00
Revenue This Year
N/A
$956.51
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.46
52 Week High
$5.39
$7.13

Technical Indicators

Market Signals
Indicator
SIDU
PROK
Relative Strength Index (RSI) 40.41 46.46
Support Level $2.01 $1.87
Resistance Level $2.63 $2.12
Average True Range (ATR) 0.30 0.16
MACD -0.15 0.01
Stochastic Oscillator 2.66 60.29

Price Performance

Historical Comparison
SIDU
PROK

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: